Literature DB >> 19228930

Menin regulates the function of hematopoietic stem cells and lymphoid progenitors.

Ivan Maillard1, Ya-Xiong Chen, Ann Friedman, Yuqing Yang, Anthony T Tubbs, Olga Shestova, Warren S Pear, Xianxin Hua.   

Abstract

Men1 is a tumor suppressor gene mutated in endocrine neoplasms. Besides its endocrine role, the Men1 gene product menin interacts with the mixed lineage leukemia (MLL) protein, a histone H3 lysine 4 methyltransferase. Although menin and MLL fusion proteins cooperate to activate Homeobox (Hox) gene expression during transformation, little is known about the normal hematopoietic functions of menin. Here, we studied hematopoiesis after Men1 ablation. Menin loss modestly impaired blood neutrophil, lymphocyte, and platelet counts. Without hematopoietic stress, multilineage and myelo-erythroid bone marrow progenitor numbers were preserved, while B lymphoid progenitors were decreased. In contrast, competitive transplantation revealed a marked functional defect of long-term hematopoietic stem cells (HSC) in the absence of menin, despite normal initial homing of progenitors to the bone marrow. HoxA9 gene expression was only modestly decreased in menin-deficient HSCs. These observations reveal a novel and essential role for menin in HSC homeostasis that was most apparent during situations of hematopoietic recovery, suggesting that menin regulates molecular pathways that are essential during the adaptive HSC response to stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228930      PMCID: PMC2647667          DOI: 10.1182/blood-2009-01-135012

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Interaction of MLL amino terminal sequences with menin is required for transformation.

Authors:  Corrado Caslini; Zhaohai Yang; Mohamad El-Osta; Thomas A Milne; Robert K Slany; Jay L Hess
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.

Authors:  Mark J Kiel; Omer H Yilmaz; Toshihide Iwashita; Osman H Yilmaz; Cox Terhorst; Sean J Morrison
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

3.  Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells.

Authors:  H Jeffrey Lawrence; Julie Christensen; Stephen Fong; Yu-Long Hu; Irving Weissman; Guy Sauvageau; R Keith Humphries; Corey Largman
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

4.  Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus.

Authors:  Celina Demers; Chandra-Prakash Chaturvedi; Jeffrey A Ranish; Gaetan Juban; Patrick Lai; Francois Morle; Ruedi Aebersold; F Jeffrey Dilworth; Mark Groudine; Marjorie Brand
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

5.  The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.

Authors:  Ya-Xiong Chen; Jizhou Yan; Karen Keeshan; Anthony T Tubbs; Haoren Wang; Albert Silva; Eric J Brown; Jay L Hess; Warren S Pear; Xianxin Hua
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

6.  Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss.

Authors:  Yaroslava Ruzankina; Carolina Pinzon-Guzman; Amma Asare; Tony Ong; Laura Pontano; George Cotsarelis; Valerie P Zediak; Marielena Velez; Avinash Bhandoola; Eric J Brown
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

7.  Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation.

Authors:  Sunita K Agarwal; Soren Impey; Shannon McWeeney; Peter C Scacheri; Francis S Collins; Richard H Goodman; Allen M Spiegel; Stephen J Marx
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

8.  Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.

Authors:  Robert W Schnepp; Ya-Xiong Chen; Haoren Wang; Tim Cash; Albert Silva; J Alan Diehl; Eric Brown; Xianxin Hua
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

9.  Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice.

Authors:  H Yagi; K Deguchi; A Aono; Y Tani; T Kishimoto; T Komori
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

10.  Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.

Authors:  Peter C Scacheri; Sean Davis; Duncan T Odom; Gregory E Crawford; Stacie Perkins; Mohamad J Halawi; Sunita K Agarwal; Stephen J Marx; Allen M Spiegel; Paul S Meltzer; Francis S Collins
Journal:  PLoS Genet       Date:  2006-04-07       Impact factor: 5.917

View more
  24 in total

1.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

2.  The role of menin in hematopoiesis.

Authors:  Ivan Maillard; Jay L Hess
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Trithorax and polycomb cooperation in MLL fusion acute leukemia.

Authors:  Helene Méreau; Juerg Schwaller
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

4.  Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Authors:  Dmitry Borkin; Shihan He; Hongzhi Miao; Katarzyna Kempinska; Jonathan Pollock; Jennifer Chase; Trupta Purohit; Bhavna Malik; Ting Zhao; Jingya Wang; Bo Wen; Hongliang Zong; Morgan Jones; Gwenn Danet-Desnoyers; Monica L Guzman; Moshe Talpaz; Dale L Bixby; Duxin Sun; Jay L Hess; Andrew G Muntean; Ivan Maillard; Tomasz Cierpicki; Jolanta Grembecka
Journal:  Cancer Cell       Date:  2015-03-26       Impact factor: 31.743

Review 5.  Menin as a hub controlling mixed lineage leukemia.

Authors:  Austin T Thiel; Jing Huang; Ming Lei; Xianxin Hua
Journal:  Bioessays       Date:  2012-07-24       Impact factor: 4.345

6.  Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.

Authors:  Morgan Jones; Jennifer Chase; Michelle Brinkmeier; Jing Xu; Daniel N Weinberg; Julien Schira; Ann Friedman; Sami Malek; Jolanta Grembecka; Tomasz Cierpicki; Yali Dou; Sally A Camper; Ivan Maillard
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

7.  An MLL-dependent network sustains hematopoiesis.

Authors:  Erika L Artinger; Bibhu P Mishra; Kristin M Zaffuto; Bin E Li; Elaine K Y Chung; Adrian W Moore; Yufei Chen; Chao Cheng; Patricia Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-06       Impact factor: 11.205

8.  The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.

Authors:  J Shi; E Wang; J Zuber; A Rappaport; M Taylor; C Johns; S W Lowe; C R Vakoc
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

9.  HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.

Authors:  Yu-Long Hu; Steve Fong; Christina Ferrell; Corey Largman; Wei-Fang Shen
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

10.  In vitro hematopoietic differentiation of mouse embryonic stem cells requires the tumor suppressor menin and is mediated by Hoxa9.

Authors:  Elizabeth Novotny; Sheila Compton; P Paul Liu; Francis S Collins; Settara C Chandrasekharappa
Journal:  Mech Dev       Date:  2009-04-22       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.